These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 552852)

  • 21. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
    Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
    Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DOPA decarboxylase activity in the nervous system and the ctenidium of the freshwater clam, Musculium (Sphaerium) transversum.
    Paparo AA; Murphy JA; Dean RC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 77(1):55-7. PubMed ID: 6141881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic and in vitro effects of GAD and GABA-T inhibitors on AADC activity and of AADC inhibitors on GAD.
    Giorgi O; Rubio MC
    Gen Pharmacol; 1981; 12(4):217-23. PubMed ID: 7250670
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N; Kuzuya F; Mori K; Sakamoto N
    Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
    Pontiroli AE; Castegnaro E; Vettaro MP; Viberti GC; Pozza G
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):36-44. PubMed ID: 318788
    [No Abstract]   [Full Text] [Related]  

  • 27. Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production.
    Sugiyama Y; Mori Y; Nara M; Kotani Y; Nagai E; Kawada H; Kitamura M; Hirano R; Shimokawa H; Nakagawa A; Minami H; Gotoh A; Sakanaka M; Iida N; Koyanagi T; Katayama T; Okamoto S; Kurihara S
    Gut Microbes; 2022; 14(1):2128605. PubMed ID: 36217238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of counteracting effect of liposomes on benserazide-induced hyperprolactinemia.
    Murialdo G; Masturzo P; Polleri A; Carolei A; Toffano G
    Neuropsychobiology; 1979; 5(6):317-21. PubMed ID: 503305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of carbidopa on prolactin, growth hormone and cortisol secretion in man.
    Brown GM; Garfinkel PE; Warsh JJ; Stancer HC
    J Clin Endocrinol Metab; 1976 Jul; 43(1):236-9. PubMed ID: 947942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors.
    Magnussen I; Van Woert MH
    Eur J Clin Pharmacol; 1982; 23(1):81-6. PubMed ID: 6182005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TSH and prolactin stimulation by the decarboxylase inhibitor benserazide in primary hypothyroidism.
    Delitala G; Devilla L; Lotti G
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):313-6. PubMed ID: 7389157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of some decarboxylase inhibitors on striatal tyramines in the mouse.
    Juorio AV
    Neuropharmacology; 1983 Jan; 22(1):71-3. PubMed ID: 6843786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site of action of methyldopa in lowering the blood pressure in man.
    Kersting F; Reid JL; Dollery CT
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():11-5. PubMed ID: 277299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of dopamine from L-3,4-dihydroxyphenylalanine by human amniotic epithelial cells.
    Elwan MA
    Eur J Pharmacol; 1998 Jul; 354(1):R1-2. PubMed ID: 9726639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Minsker DH; Stokes AL
    Experientia; 1974 Sep; 30(9):1051-3. PubMed ID: 4412113
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition in vitro of the enzymes of the oxidative pathway of tryptophan metabolism and of nicotinamide nucleotide synthesis by benserazide, carbidopa and isoniazid.
    Bender DA
    Biochem Pharmacol; 1980 Mar; 29(5):707-12. PubMed ID: 20227944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No evidence for a peripheral effect of L-DOPA on plasma prolactin in the rat.
    Mattheij JA; Brouwer GM; Hanstede JG; Swarts JJ
    Life Sci; 1982 Aug; 31(9):915-21. PubMed ID: 7176820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of peripheral sympathetic function by alpha-monofluoromethyldopa, an irreversible inhibitor of aromatic amino acid decarboxylase [proceedings].
    Fozard JR; Palfreyman MG; Spedding M; Wagner J; Woodward JK
    Br J Pharmacol; 1979 Nov; 67(3):461P. PubMed ID: 497578
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of carbidopa and L-dopa to suppress the prolactin stimulating effect of sulpiride in normal man.
    Zanoboni A; Zanoboni-Muciaccia W; Gattei G; Crespi R
    Farmaco Prat; 1980 Oct; 35(10):510-5. PubMed ID: 7449936
    [No Abstract]   [Full Text] [Related]  

  • 40. Determination of aromatic-L-amino acid decarboxylase in human plasma.
    Boomsma F; van der Hoorn FA; Schalekamp MA
    Clin Chim Acta; 1986 Sep; 159(2):173-83. PubMed ID: 3769207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.